The global market for Anti-inflammatory Therapeutics was estimated to be worth US$ 110540 million in 2023 and is forecast to a readjusted size of US$ 168130 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030.

Anti-inflammatory Therapeutics Market

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.

The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Anti-inflammatory Therapeutics Market Report

Report Metric	Details
Report Name	Anti-inflammatory Therapeutics Market
Forecasted market size in 2030	US$ 168130 million
CAGR	6.1%
Forecasted years	2024 - 2030
Segment by Type	Anti-inflammatory Biologics Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Corticosteroids Others
Segment by Application	Arthritis Respiratory Diseases Dermatology Gastroenterology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Anti-inflammatory Therapeutics in global and regional level.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Therapeutics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Anti-inflammatory Therapeutics Market size in 2030?

Ans: The Anti-inflammatory Therapeutics Market size in 2030 will be US$ 168130 million.

What is the AbbVie share in Anti-inflammatory Therapeutics Market?

Ans: AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share.

What is the Johnson & Johnson share in Anti-inflammatory Therapeutics Market?

Ans: Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Who are the main players in the Anti-inflammatory Therapeutics Market report?

Ans: The main players in the Anti-inflammatory Therapeutics Market are AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA

What are the Application segmentation covered in the Anti-inflammatory Therapeutics Market report?

Ans: The Applications covered in the Anti-inflammatory Therapeutics Market report are Arthritis, Respiratory Diseases, Dermatology, Gastroenterology, Others

What are the Type segmentation covered in the Anti-inflammatory Therapeutics Market report?

Ans: The Types covered in the Anti-inflammatory Therapeutics Market report are Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Others

1 Study Coverage

1.1 Anti-inflammatory Therapeutics Product Introduction

1.2 Market by Type

1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Anti-inflammatory Biologics

1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

1.2.4 Corticosteroids

1.2.5 Others

1.3 Market by Application

1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Arthritis

1.3.3 Respiratory Diseases

1.3.4 Dermatology

1.3.5 Gastroenterology

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Anti-inflammatory Therapeutics Market Size Estimates and Forecasts

2.2 Anti-inflammatory Therapeutics Market Size by Region: 2023 Versus 2030

2.2.1 Global Anti-inflammatory Therapeutics Revenue by Region: 2019-2024

2.2.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2025-2030)

2.2.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2019-2030)

3 Global Anti-inflammatory Therapeutics by Company

3.1 Global Anti-inflammatory Therapeutics Revenue by Company (2019-2024)

3.2 Global Anti-inflammatory Therapeutics Revenue Share by Company (2019-2024)

3.3 Competitive Landscape

3.3.1 Key Anti-inflammatory Therapeutics Companies around the World: Ranking by Revenue

3.3.2 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.3.3 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Anti-inflammatory Therapeutics Companies Headquarters & Product Type

3.4.1 Anti-inflammatory Therapeutics Companies Headquarters

3.4.2 Global Anti-inflammatory Therapeutics Companies Product & Service

3.4.3 Date of International Companies Enter into Anti-inflammatory Therapeutics Market

3.5 Global Anti-inflammatory Therapeutics Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 AbbVie

4.1.1 AbbVie Company Information

4.1.2 AbbVie Description, Business Overview

4.1.3 AbbVie Anti-inflammatory Therapeutics Products Offered

4.1.4 AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.1.5 AbbVie Anti-inflammatory Therapeutics Revenue by Product in 2023

4.1.6 AbbVie Anti-inflammatory Therapeutics Revenue by Application in 2023

4.1.7 AbbVie Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.1.8 AbbVie Recent Developments

4.2 Johnson & Johnson

4.2.1 Johnson & Johnson Company Information

4.2.2 Johnson & Johnson Description, Business Overview

4.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Products Offered

4.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.2.5 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Product in 2023

4.2.6 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Application in 2023

4.2.7 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.2.8 Johnson & Johnson Recent Developments

4.3 Amgen Inc

4.3.1 Amgen Inc Company Information

4.3.2 Amgen Inc Description, Business Overview

4.3.3 Amgen Inc Anti-inflammatory Therapeutics Products Offered

4.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.3.5 Amgen Inc Anti-inflammatory Therapeutics Revenue by Product in 2023

4.3.6 Amgen Inc Anti-inflammatory Therapeutics Revenue by Application in 2023

4.3.7 Amgen Inc Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.3.8 Amgen Inc Recent Developments

4.4 AstraZeneca PLC

4.4.1 AstraZeneca PLC Company Information

4.4.2 AstraZeneca PLC Description, Business Overview

4.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Products Offered

4.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.4.5 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Product in 2023

4.4.6 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Application in 2023

4.4.7 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.4.8 AstraZeneca PLC Recent Developments

4.5 Pfizer, Inc

4.5.1 Pfizer, Inc Company Information

4.5.2 Pfizer, Inc Description, Business Overview

4.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Products Offered

4.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.5.5 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Product in 2023

4.5.6 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Application in 2023

4.5.7 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.5.8 Pfizer, Inc Recent Developments

4.6 Novartis

4.6.1 Novartis Company Information

4.6.2 Novartis Description, Business Overview

4.6.3 Novartis Anti-inflammatory Therapeutics Products Offered

4.6.4 Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.6.5 Novartis Anti-inflammatory Therapeutics Revenue by Product in 2023

4.6.6 Novartis Anti-inflammatory Therapeutics Revenue by Application in 2023

4.6.7 Novartis Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.6.8 Novartis Recent Development

4.7 Roche

4.7.1 Roche Company Information

4.7.2 Roche Description, Business Overview

4.7.3 Roche Anti-inflammatory Therapeutics Products Offered

4.7.4 Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.7.5 Roche Anti-inflammatory Therapeutics Revenue by Product in 2023

4.7.6 Roche Anti-inflammatory Therapeutics Revenue by Application in 2023

4.7.7 Roche Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.7.8 Roche Recent Development

4.8 Merck

4.8.1 Merck Company Information

4.8.2 Merck Description, Business Overview

4.8.3 Merck Anti-inflammatory Therapeutics Products Offered

4.8.4 Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.8.5 Merck Anti-inflammatory Therapeutics Revenue by Product in 2023

4.8.6 Merck Anti-inflammatory Therapeutics Revenue by Application in 2023

4.8.7 Merck Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.8.8 Merck Recent Development

4.9 Sanofi

4.9.1 Sanofi Company Information

4.9.2 Sanofi Description, Business Overview

4.9.3 Sanofi Anti-inflammatory Therapeutics Products Offered

4.9.4 Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.9.5 Sanofi Anti-inflammatory Therapeutics Revenue by Product in 2023

4.9.6 Sanofi Anti-inflammatory Therapeutics Revenue by Application in 2023

4.9.7 Sanofi Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.9.8 Sanofi Recent Development

4.10 GlaxoSmithKline

4.10.1 GlaxoSmithKline Company Information

4.10.2 GlaxoSmithKline Description, Business Overview

4.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Products Offered

4.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.10.5 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Product in 2023

4.10.6 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Application in 2023

4.10.7 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.10.8 GlaxoSmithKline Recent Development

4.11 Sun Pharmaceutical Industries Ltd

4.11.1 Sun Pharmaceutical Industries Ltd Company Information

4.11.2 Sun Pharmaceutical Industries Ltd Description, Business Overview

4.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Products Offered

4.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.11.5 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Product in 2023

4.11.6 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Application in 2023

4.11.7 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.11.8 Sun Pharmaceutical Industries Ltd Recent Development

4.12 TEVA

4.12.1 TEVA Company Information

4.12.2 TEVA Description, Business Overview

4.12.3 TEVA Anti-inflammatory Therapeutics Products Offered

4.12.4 TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (2019-2024)

4.12.5 TEVA Anti-inflammatory Therapeutics Revenue by Product in 2023

4.12.6 TEVA Anti-inflammatory Therapeutics Revenue by Application in 2023

4.12.7 TEVA Anti-inflammatory Therapeutics Revenue by Geographic Area in 2023

4.12.8 TEVA Recent Development

5 Breakdown Data by Type

5.1 Global Anti-inflammatory Therapeutics Revenue by Type (2019-2024)

5.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2025-2030)

5.3 Anti-inflammatory Therapeutics Revenue Market Share by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Anti-inflammatory Therapeutics Revenue by Application (2019-2024)

6.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2025-2030)

6.3 Anti-inflammatory Therapeutics Revenue Market Share by Application (2019-2030)

7 North America

7.1 North America Anti-inflammatory Therapeutics Market Size YoY Growth 2019-2030

7.2 North America Anti-inflammatory Therapeutics Market Facts & Figures by Country (2019-2030)

7.3 North America Anti-inflammatory Therapeutics Revenue by Type (2019-2024)

7.4 North America Anti-inflammatory Therapeutics Revenue by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Facts & Figures by Region (2019-2030)

8.3 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2019-2024)

8.4 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2019-2024)

9 Europe

9.1 Europe Anti-inflammatory Therapeutics Market Size YoY Growth 2019-2030

9.2 Europe Anti-inflammatory Therapeutics Market Facts & Figures by Country (2019-2030)

9.3 Europe Anti-inflammatory Therapeutics Revenue by Type (2019-2024)

9.4 Europe Anti-inflammatory Therapeutics Revenue by Application (2019-2024)

10 Latin America

10.1 Latin America Anti-inflammatory Therapeutics Market Size YoY Growth 2019-2030

10.2 Latin America Anti-inflammatory Therapeutics Market Facts & Figures by Country (2019-2030)

10.3 Latin America Anti-inflammatory Therapeutics Revenue by Type (2019-2024)

10.4 Latin America Anti-inflammatory Therapeutics Revenue by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Anti-inflammatory Therapeutics Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Anti-inflammatory Therapeutics Market Facts & Figures by Country (2019-2030)

11.3 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Type (2019-2024)

11.4 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Anti-inflammatory Therapeutics Supply Chain Analysis

12.2 Anti-inflammatory Therapeutics Key Raw Materials and Upstream Suppliers

12.3 Anti-inflammatory Therapeutics Clients Analysis

12.4 Anti-inflammatory Therapeutics Sales Channel and Sales Model Analysis

12.4.1 Anti-inflammatory Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Anti-inflammatory Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Anti-inflammatory Therapeutics Distributors

13 Market Dynamics

13.1 Anti-inflammatory Therapeutics Industry Trends

13.2 Anti-inflammatory Therapeutics Market Drivers

13.3 Anti-inflammatory Therapeutics Market Challenges

13.4 Anti-inflammatory Therapeutics Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sun Pharmaceutical Industries Ltd.

TEVA

AbbVie

List of Tables

Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Companies of Anti-inflammatory Biologics

Table 3. Major Companies of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Table 4. Major Companies of Corticosteroids

Table 5. Major Companies of Others

Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2023 VS 2030

Table 8. Global Anti-inflammatory Therapeutics Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Anti-inflammatory Therapeutics Revenue by Company (2019-2024) & (US$ Million)

Table 11. Anti-inflammatory Therapeutics Revenue Share by Company (2019-2024)

Table 12. Ranking of Global Top Anti-inflammatory Therapeutics Players by Revenue (US$ Million) in 2023

Table 13. Global Anti-inflammatory Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 14. Global Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2023)

Table 15. Global Anti-inflammatory Therapeutics Companies Headquarters

Table 16. Global Anti-inflammatory Therapeutics Companies Product & Service

Table 17. Date of International Companies Enter into Anti-inflammatory Therapeutics Market

Table 18. Global Anti-inflammatory Therapeutics Mergers & Acquisitions, Expansion Plans

Table 19. AbbVie Company Information

Table 20. AbbVie Description and Business Overview

Table 21. AbbVie Anti-inflammatory Therapeutics Product

Table 22. AbbVie Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 23. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 24. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 25. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 26. AbbVie Recent Development

Table 27. Johnson & Johnson Company Information

Table 28. Johnson & Johnson Description and Business Overview

Table 29. Johnson & Johnson Anti-inflammatory Therapeutics Product

Table 30. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 31. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 32. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 33. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 34. Johnson & Johnson Recent Development

Table 35. Amgen Inc Company Information

Table 36. Amgen Inc Description and Business Overview

Table 37. Amgen Inc Anti-inflammatory Therapeutics Product

Table 38. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 39. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 40. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 41. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 42. Amgen Inc Recent Development

Table 43. AstraZeneca PLC Company Information

Table 44. AstraZeneca PLC Description and Business Overview

Table 45. AstraZeneca PLC Anti-inflammatory Therapeutics Product

Table 46. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 47. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 48. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 49. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 50. AstraZeneca PLC Recent Development

Table 51. Pfizer, Inc Company Information

Table 52. Pfizer, Inc Description and Business Overview

Table 53. Pfizer, Inc Anti-inflammatory Therapeutics Product

Table 54. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 55. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 56. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 57. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 58. Pfizer, Inc Recent Development

Table 59. Novartis Company Information

Table 60. Novartis Description and Business Overview

Table 61. Novartis Anti-inflammatory Therapeutics Product

Table 62. Novartis Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 63. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 64. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 65. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 66. Novartis Recent Development

Table 67. Roche Company Information

Table 68. Roche Description and Business Overview

Table 69. Roche Anti-inflammatory Therapeutics Product

Table 70. Roche Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 71. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 72. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 73. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 74. Roche Recent Development

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Anti-inflammatory Therapeutics Product

Table 78. Merck Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 79. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 80. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 81. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 82. Merck Recent Development

Table 83. Sanofi Company Information

Table 84. Sanofi Description and Business Overview

Table 85. Sanofi Anti-inflammatory Therapeutics Product

Table 86. Sanofi Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 87. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 88. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 89. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 90. Sanofi Recent Development

Table 91. GlaxoSmithKline Company Information

Table 92. GlaxoSmithKline Description and Business Overview

Table 93. GlaxoSmithKline Anti-inflammatory Therapeutics Product

Table 94. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 95. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 96. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 97. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 98. GlaxoSmithKline Recent Development

Table 99. Sun Pharmaceutical Industries Ltd Company Information

Table 100. Sun Pharmaceutical Industries Ltd Description and Business Overview

Table 101. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product

Table 102. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 103. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 104. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 105. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 106. Sun Pharmaceutical Industries Ltd Recent Development

Table 107. TEVA Company Information

Table 108. TEVA Description and Business Overview

Table 109. TEVA Anti-inflammatory Therapeutics Product

Table 110. TEVA Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)

Table 111. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2023

Table 112. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2023

Table 113. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2023

Table 114. TEVA Recent Development

Table 115. Global Anti-inflammatory Therapeutics Revenue by Type (2019-2024) & (US$ Million)

Table 116. Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 117. Global Anti-inflammatory Therapeutics Revenue by Application (2019-2024) & (US$ Million)

Table 118. Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 119. North America Anti-inflammatory Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 120. North America Anti-inflammatory Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 121. North America Anti-inflammatory Therapeutics Revenue by Type (2019-2024) & (US$ Million)

Table 122. North America Anti-inflammatory Therapeutics Revenue by Application (2019-2024) & (US$ Million)

Table 123. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2019-2030) & (US$ Million)

Table 124. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2025-2030) & (US$ Million)

Table 125. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2019-2024) & (US$ Million)

Table 126. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2019-2024) & (US$ Million)

Table 127. Europe Anti-inflammatory Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 128. Europe Anti-inflammatory Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 129. Europe Anti-inflammatory Therapeutics Revenue by Type (2019-2024) & (US$ Million)

Table 130. Europe Anti-inflammatory Therapeutics Revenue by Application (2019-2024) & (US$ Million)

Table 131. Latin America Anti-inflammatory Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 132. Latin America Anti-inflammatory Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 133. Latin America Anti-inflammatory Therapeutics Revenue by Type (2019-2024) & (US$ Million)

Table 134. Latin America Anti-inflammatory Therapeutics Revenue by Application (2019-2024) & (US$ Million)

Table 135. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Country (2019-2024) & (US$ Million)

Table 136. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Country (2025-2030) & (US$ Million)

Table 137. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Type (2019-2024) & (US$ Million)

Table 138. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Application (2019-2024) & (US$ Million)

Table 139. Anti-inflammatory Therapeutics Key Raw Materials, Industry Status and Trend

Table 140. Anti-inflammatory Therapeutics Key Raw Materials and Upstream Suppliers

Table 141. Anti-inflammatory Therapeutics Clients Status and Trend

Table 142. Anti-inflammatory Therapeutics Typical Clients

Table 143. Anti-inflammatory Therapeutics Distributors

Table 144. Anti-inflammatory Therapeutics Market Trends

Table 145. Anti-inflammatory Therapeutics Market Drivers

Table 146. Anti-inflammatory Therapeutics Market Challenges

Table 147. Anti-inflammatory Therapeutics Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-inflammatory Therapeutics Product Picture

Figure 2. Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2023 & 2030

Figure 3. Anti-inflammatory Biologics Product Picture

Figure 4. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture

Figure 5. Corticosteroids Product Picture

Figure 6. Others Product Picture

Figure 7. Global Anti-inflammatory Therapeutics Revenue Market Share by Application in 2023 & 2030

Figure 8. Arthritis

Figure 9. Respiratory Diseases

Figure 10. Dermatology

Figure 11. Gastroenterology

Figure 12. Others

Figure 13. Anti-inflammatory Therapeutics Report Years Considered

Figure 14. Global Anti-inflammatory Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Anti-inflammatory Therapeutics Market Size 2019-2030 (US$ Million)

Figure 16. Global Anti-inflammatory Therapeutics Market Size Market Share by Region: 2023 Versus 2030

Figure 17. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2019-2030)

Figure 18. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Type (2019-2030)

Figure 20. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Application (2019-2030)

Figure 21. North America Anti-inflammatory Therapeutics Revenue 2019-2030 (US$ Million)

Figure 22. North America Anti-inflammatory Therapeutics Revenue Market Share by Type (2019-2024)

Figure 23. North America Anti-inflammatory Therapeutics Revenue Market Share by Application (2019-2024)

Figure 24. Asia-Pacific Anti-inflammatory Therapeutics Revenue 2019-2030 (US$ Million)

Figure 25. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Region (2019-2030)

Figure 26. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Type (2019-2024)

Figure 27. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Application (2019-2024)

Figure 28. Europe Anti-inflammatory Therapeutics Revenue Growth Rate 2019-2030 (US$ Million)

Figure 29. Europe Anti-inflammatory Therapeutics Revenue Market Share by Country (2019-2030)

Figure 30. Europe Anti-inflammatory Therapeutics Revenue Market Share by Type (2019-2024)

Figure 31. Europe Anti-inflammatory Therapeutics Revenue Market Share by Application (2019-2024)

Figure 32. Latin America Anti-inflammatory Therapeutics Revenue Growth Rate 2019-2030 (US$ Million)

Figure 33. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Country (2019-2024)

Figure 34. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Type (2019-2024)

Figure 35. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Application (2019-2024)

Figure 36. Middle East and Africa Anti-inflammatory Therapeutics Revenue Growth Rate 2019-2030 (US$ Million)

Figure 37. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Country (2019-2030)

Figure 38. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Type (2019-2024)

Figure 39. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Application (2019-2024)

Figure 40. Anti-inflammatory Therapeutics Supply Chain (Upstream and Downstream Market)

Figure 41. Global Production Market Share of Anti-inflammatory Therapeutics Raw Materials by Region in 2023

Figure 42. Anti-inflammatory Therapeutics Distribution Channels

Figure 43. Global Anti-inflammatory Therapeutics Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 44. Global Anti-inflammatory Therapeutics Percentage 2019-2030: Online Sales VS Offline Sales

Figure 45. Bottom-up and Top-down Approaches for This Report

Figure 46. Data Triangulation

Figure 47. Key Executives Interviewed

Figure 48. Global Anti-inflammatory Therapeutics Percentage 2019-2030: Online Sales VS Offline Sales

Figure 49. Bottom-up and Top-down Approaches for This Report

Figure 50. Data Triangulation

Figure 51. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions